The book presents in detail the six steps to be taken from terminology to treatment recommendations of new cancer therapy-associated skin and mucosal side effects. The new cancer therapies are the so-called targeted therapies.
The TARGET-system provides a roadmap developed to support representatives of pharmaceutical companies, clinicians, researchers, and trainers in implementing appropriate treatment options for oncology drug-associated side effects.
The roadmap steps include Terminology, Assessment, Reporting, Grading, Education, and Treatment. This system enables the provider to limit the side effects of targeted therapies and promotes patient compliance with such therapies, avoiding discontinuation or dose adjustments. When treatment is initiated early, at the onset of a side effect, the symptoms may be more readily controlled.
When applying the TARGET-system steps in a busy clinical setting or during research protocols, it will undoubtedly prolong the duration of a patient on targeted therapy/immuno-oncology and improve the quality of life of people who depend on these drugs.